Embecta Corp - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
EMBC Nasdaq 3841 https://www.embecta.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Embecta Corp

embecta to Report Fiscal Second Quarter 2024 Financial Results - Apr 23rd, 2024 9:00 pm
embecta-sponsored Educational Symposium and Abstracts at ATTD Highlight Role of Insulin Pumps in the Management of Type 2 Diabetes - Mar 6th, 2024 11:00 am
Embecta (NASDAQ:EMBC) Has Affirmed Its Dividend Of $0.15 - Feb 13th, 2024 10:17 am
Embecta Corp. (NASDAQ:EMBC) Q1 2024 Earnings Call Transcript - Feb 10th, 2024 1:55 pm
Q1 2024 Embecta Corp Earnings Call - Feb 10th, 2024 3:07 am
Why Embecta Stock Is Tanking Today - Feb 9th, 2024 4:43 pm
Embecta Corp. (EMBC) Surpasses Q1 Earnings and Revenue Estimates - Feb 9th, 2024 12:45 pm
Embecta Corp (EMBC) Reports Modest Revenue Growth and Decline in Profitability in Q1 Fiscal 2024 - Feb 9th, 2024 12:07 pm
Embecta Corp. Reports First Quarter Fiscal 2024 Financial Results - Feb 9th, 2024 11:30 am
embecta Announces Quarterly Cash Dividend - Feb 9th, 2024 11:00 am
embecta to Participate in the 11th Annual BTIG MedTech Conference - Feb 7th, 2024 10:00 pm
embecta to Report Fiscal First Quarter 2024 Financial Results - Jan 24th, 2024 10:00 pm
16 Most Profitable New Stocks Today - Jan 21st, 2024 1:33 pm
embecta Announces FDA 510(k) Submission for Insulin Patch Pump - Jan 9th, 2024 11:00 am
Zacks Investment Ideas feature highlights: Beacon Roofing Supply, Embecta and Western Midstream Partners - Dec 21st, 2023 8:46 am
Time to Buy These Intriguing Additions to Zacks Rank #1 (Strong Buy) List - Dec 20th, 2023 7:44 pm
embecta to Participate at the 42nd Annual J.P. Morgan Healthcare Conference - Dec 14th, 2023 10:00 pm
No embecta-made syringes impacted by FDA safety communication - Dec 1st, 2023 11:00 am
Embecta Corp's Dividend Analysis - Dec 1st, 2023 10:13 am
embecta to Participate in Investor Conferences - Nov 29th, 2023 10:00 pm